These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 19059957)
1. Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Davies RJ; Morrell NW Chest; 2008 Dec; 134(6):1271-1277. PubMed ID: 19059957 [TBL] [Abstract][Full Text] [Related]
2. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Orriols M; Gomez-Puerto MC; Ten Dijke P Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Morrell NW Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373 [TBL] [Abstract][Full Text] [Related]
4. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Atkinson C; Stewart S; Upton PD; Machado R; Thomson JR; Trembath RC; Morrell NW Circulation; 2002 Apr; 105(14):1672-8. PubMed ID: 11940546 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357 [TBL] [Abstract][Full Text] [Related]
6. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis. Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692 [TBL] [Abstract][Full Text] [Related]
7. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension. Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995 [TBL] [Abstract][Full Text] [Related]
8. The Role of Bone Morphogenetic Protein Receptor Type 2 ( Devendran A; Kar S; Bailey R; Trivieri MG Cells; 2022 Nov; 11(23):. PubMed ID: 36497082 [TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease. Upton PD; Morrell NW Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549 [TBL] [Abstract][Full Text] [Related]
10. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267 [TBL] [Abstract][Full Text] [Related]
11. Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension. Morrell NW Adv Exp Med Biol; 2010; 661():251-64. PubMed ID: 20204735 [TBL] [Abstract][Full Text] [Related]
12. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Wong WK; Knowles JA; Morse JH Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577 [TBL] [Abstract][Full Text] [Related]
14. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Morrell NW; Yang X; Upton PD; Jourdan KB; Morgan N; Sheares KK; Trembath RC Circulation; 2001 Aug; 104(7):790-5. PubMed ID: 11502704 [TBL] [Abstract][Full Text] [Related]
15. The role of genetics in pulmonary arterial hypertension. Ma L; Chung WK J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446 [TBL] [Abstract][Full Text] [Related]
16. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988 [TBL] [Abstract][Full Text] [Related]
17. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866 [TBL] [Abstract][Full Text] [Related]
18. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Beppu H; Ichinose F; Kawai N; Jones RC; Yu PB; Zapol WM; Miyazono K; Li E; Bloch KD Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1241-7. PubMed ID: 15286002 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes. Yuan SM Pediatr Neonatol; 2018 Apr; 59(2):112-119. PubMed ID: 28967497 [TBL] [Abstract][Full Text] [Related]